Table 1 The mean and range of maximum SUV in patients of each disease
From: F-18 fluorodeoxyglucose positron emission tomography for differential diagnosis of pancreatic tumors
Disease | Malignant/Benign | No. of Patients | Mean SUV max (Range) |
|---|---|---|---|
Pancreatic ductal cancer | Malignant | 80 | 5.4 (1.6-11.8) |
Mass-forming chronic pancreatitis | Benign | 10 | 2.0 (1.2-5.3) |
Intraductal papillary mucinous carcinoma | Malignant | 18 | 5.5 (1.5-13.8) |
Intraductal papillary mucinous neoplasm | Benign | 12 | 1.7 (1.1-2.3) |
Neuroendocrine carcinoma | Malignant | 4 | Â |
      Non-functioning islet cell carcinoma |  | 4 | 9.0 (3.3-13.8) |
Neuroendocrine tumor | Benign | 12 | Â |
      Insulinoma |  | 7 | 1.6 (1.1-2.0) |
      Glucagonoma |  | 2 | 1.9 (1.8-2.0) |
      Gastrinoma |  | 1 | 1.8 |
      Non-functioning islet cell tumor |  | 2 | 2.2 (1.9-2.4) |